Perhaps they wanted to include information on the Seragen upcoming deal? Or, better yet, perhaps they've got the Panretin Gel NDA ready.
Or, better yet, perhaps they've decided to buy McDonalds, so they can add more fat to the hamburgers, and then create a bigger market for their Leptin drug?
Man oh man! Greg, I can't take the suspense anymore! I just can't take it! ARGHHHH!!!
I'm going to make up my own LGND earnings report:
============================================================>
April 14, 1998, 8pm EST: Ligand announces blockbuster earnings of .87 per share based on $130 million in revenues.
Spokesman said that, even though they weren't really ready with the report, they copied an earnings estimate from an old H&Q report. Even though the H&Q report was an annual number, the LGND spokesman said that the stock holders would like the number anyway!
On the NDA homefront, the spokesman said that one of the stupid, naked, ugly mice, that was treated with Panretin, was sexually stimulated. This was hard to believe since these ugly, naked mice usually would rather hump a cat, rather than each other. Still in all, LGND plans to file for an IND for the purposes of a "sexual stimulation of naked, ugly rodents", as soon as possible.
They predict that they will make about .87 per share, based on $130 million in revenues in 1999, based on the number of ugly, naked mices that have available credit.
|
